Skip to content

The Effect of Fact Versus Myth Messages on Receipt of Influenza Vaccination

The Effect of Fact Versus Myth Messages on Receipt of Influenza Vaccination

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01009645
Enrollment
125
Registered
2009-11-09
Start date
2009-09-30
Completion date
2010-04-30
Last updated
2023-10-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Influenza Vaccination

Keywords

education, vaccination, preventive service, Prevention & Control

Brief summary

The purpose of this study is to evaluate whether message design of educational materials increases vaccination rates among participants.

Interventions

BEHAVIORALFact Only Education Message

Participants randomized to this intervention will receive an educational brochure listing the facts of the influenza vaccine.

BEHAVIORALFact and Myth Educational Message

Participants randomized to this intervention will receive an educational brochure listing the facts and myths of the influenza vaccine.

BEHAVIORALFact, Myth, Why Educational Message

Participants randomized to this intervention will receive an educational brochure listing the facts, myths, and refutation of the myths of the influenza vaccine.

BEHAVIORALControl Educational Message

Participants randomized to this intervention will receive an educational brochure created and used by the CDC in a previous influenza season.

Sponsors

National Institute on Aging (NIA)
CollaboratorNIH
Northwestern University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
SINGLE (Subject)

Eligibility

Sex/Gender
ALL
Age
50 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Participant must have a scheduled appointment at least 6 weeks in advance in either the GIM or Geriatrics clinics at NMFF. * Participant must be a patient of Northwestern Medical Faculty Foundation. * Participant does not intend to receive the influenza vaccine.

Exclusion criteria

* Participant has a diagnosis of Alzheimer's Disease or Dementia * Participant has received an influenza vaccination during either the last influenza season or the current. * The scheduled visit is the participant's first time being seen by this doctor (appointment is to establish care in the clinic).

Design outcomes

Primary

MeasureTime frameDescription
Influenza Vaccination1 week following randomizationThe primary outcome is receipt of influenza vaccination at appointment directly following the post-test. A pre-test was completed by participants during a telephone interview that occurred approximately two weeks prior to a scheduled clinic appointment. The post-test was completed via an in-person interview by participants immediately prior to their scheduled appointment. That is, the participants met with the Research Assistant, completed the post-test, and then proceeded to see their physician for a previously scheduled office visit.

Secondary

MeasureTime frameDescription
Recall Accuracy1 week following receipt of messageParticipants were given 8 statements about the flu/flu shot and asked to recall if they had seen the statement on the message they received via FedEx. Participants responded that statement had been presented as a fact, presented as a myth, presented, but I don't recall if it was a fact or a myth, or not presented. Participants scored 1 for each correct answer; 0 for each incorrect answer or for response I don't recall. Recall accuracy was calculated among each message format, range for recall accuracy was 0 - 8 with 0 indicating no correct answers and 8 representing 100% accuracy. Thus units of measurement are units on a scale to represent participant scores out of 8 on the recall items.

Countries

United States

Participant flow

Recruitment details

Eligible participants had scheduled appointments in a private medical clinic during October 2009 - March 2010. Potential participants were sent an opt-out letter indicating that they would be receiving a phone call to invite them to participate in a study if interested; those not opting out were contacted and asked to participate.

Pre-assignment details

If potential participants had already received the seasonal influenza vaccination for 2009 - 2010 or responded on the phone that they definitely intended to receive the vaccine, they were excluded from the study. These screening questions were asked prior to enrollment into the study.

Participants by arm

ArmCount
Fact Only
The educational message used will contain facts only.
31
Fact and Myth
The educational material seen by this arm will contain facts and myths only.
31
Fact, Myth, Why
The educational material seen by this arm will contain myths, facts, and refutations of the myths.
32
Control
This arm will receive fact/myth educational materials originally developed and used by the CDC.
31
Total125

Withdrawals & dropouts

PeriodReasonFG000FG001FG002FG003
Overall StudyLost to Follow-up2845

Baseline characteristics

CharacteristicFact and MythFact, Myth, WhyFact OnlyControlTotal
Age, Categorical
<=18 years
0 Participants0 Participants0 Participants0 Participants0 Participants
Age, Categorical
>=65 years
11 Participants9 Participants13 Participants15 Participants48 Participants
Age, Categorical
Between 18 and 65 years
20 Participants23 Participants18 Participants16 Participants77 Participants
Age, Continuous61.13 years
STANDARD_DEVIATION 7.46
63.34 years
STANDARD_DEVIATION 9.64
62.8 years
STANDARD_DEVIATION 11.27
65.35 years
STANDARD_DEVIATION 8.4
63.16 years
STANDARD_DEVIATION 9.43
Region of Enrollment
United States
31 participants32 participants31 participants31 participants125 participants
Sex: Female, Male
Female
24 Participants23 Participants27 Participants24 Participants98 Participants
Sex: Female, Male
Male
7 Participants9 Participants4 Participants7 Participants27 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
EG002
affected / at risk
EG003
affected / at risk
deaths
Total, all-cause mortality
— / —— / —— / —— / —
other
Total, other adverse events
0 / 310 / 310 / 320 / 31
serious
Total, serious adverse events
0 / 310 / 310 / 320 / 31

Outcome results

Primary

Influenza Vaccination

The primary outcome is receipt of influenza vaccination at appointment directly following the post-test. A pre-test was completed by participants during a telephone interview that occurred approximately two weeks prior to a scheduled clinic appointment. The post-test was completed via an in-person interview by participants immediately prior to their scheduled appointment. That is, the participants met with the Research Assistant, completed the post-test, and then proceeded to see their physician for a previously scheduled office visit.

Time frame: 1 week following randomization

ArmMeasureValue (NUMBER)
Fact OnlyInfluenza Vaccination4 participants
Fact and MythInfluenza Vaccination1 participants
Fact, Myth, WhyInfluenza Vaccination3 participants
ControlInfluenza Vaccination4 participants
Comparison: Contrast analysis was used to assess difference in vaccination status. The first contrast assessed whether or not the three newly created messages (Fact Only (FO), Fact/Myth (FM), and Fact/Myth/Refutation (FMR)) were as a group significantly different than the control message.p-value: <0.05Contrast Analysis
Comparison: Contrast analysis was used to assess difference in vaccination status. The second contrast assessed whether the FO and FMR conditions were significantly different from the FM message.p-value: <0.05Contrast Analysis
Comparison: Contrast analysis was used to assess difference in vaccination status. The third contrast assessed whether the FO and the FMR message conditions were significantly different.p-value: <0.05Contrast Analysis
Secondary

Recall Accuracy

Participants were given 8 statements about the flu/flu shot and asked to recall if they had seen the statement on the message they received via FedEx. Participants responded that statement had been presented as a fact, presented as a myth, presented, but I don't recall if it was a fact or a myth, or not presented. Participants scored 1 for each correct answer; 0 for each incorrect answer or for response I don't recall. Recall accuracy was calculated among each message format, range for recall accuracy was 0 - 8 with 0 indicating no correct answers and 8 representing 100% accuracy. Thus units of measurement are units on a scale to represent participant scores out of 8 on the recall items.

Time frame: 1 week following receipt of message

ArmMeasureValue (MEAN)Dispersion
Fact OnlyRecall Accuracy3.13 units on a scaleStandard Deviation 1.66
Fact and MythRecall Accuracy4.52 units on a scaleStandard Deviation 1.96
Fact, Myth, WhyRecall Accuracy5.67 units on a scaleStandard Deviation 1.65
ControlRecall Accuracy4.77 units on a scaleStandard Deviation 1.82
p-value: <0.05ANOVA

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026